Equity Profile

BSX

Boston Scientific Corporation

Health CareHealth Care Equipment$76.9B

Feb10Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EST

Company Snapshot

Boston Scientific Corporation (BSX) is a leading medical device company that develops and manufactures a wide range of products used in various medical fields, including cardiology, urology, and endoscopy. With a market cap of $77 billion, the company plays a crucial role in the healthcare sector, focusing on improving patient outcomes through innovative technology.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, crucial for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BSX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+5.92%

Avg Stock Reaction

+0.45%

Last Quarter Recap

In Q1-2026, Boston Scientific reported an EPS of $0.80, matching analyst expectations and resulting in a positive stock reaction of nearly 9% the following day. The company has consistently beaten EPS estimates in recent quarters, showcasing strong operational performance.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Boston Scientific's upcoming earnings are mixed, given the lack of analyst estimates and management guidance. Investors are keen to see if the company can continue its trend of beating EPS expectations.

Bull Case

The optimistic view hinges on Boston Scientific continuing its strong performance, potentially reporting higher-than-expected EPS and revenue growth, which could drive the stock higher.

Bear Case

On the flip side, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, especially given the recent volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's history of beating EPS estimates, this number will be crucial for investor sentiment and stock performance.

How is revenue growth trending in key segments?

Understanding revenue growth in critical areas will help gauge the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Boston Scientific's ability to continue its streak of EPS beats, especially given its recent operational improvements.

Supporting Evidence

The company has consistently surprised on the upside with a 100% EPS beat rate over the last eight quarters.

The options market is pricing a lower move than historical averages, suggesting potential for greater volatility.

Recent performance trends indicate strong demand in key segments, which may not be fully reflected in current estimates.

Key Risk

If the EPS comes in below $0.75, it could challenge the current positive sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized, especially given the company's strong track record of beating EPS estimates.

Bull Confirmed If

An EPS of $0.85 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.75 would signal potential issues, confirming the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±1.36%

Historical Avg

±5.3%

Pricing cheap

The options market is pricing in a modest move of about 1.36%, suggesting that traders expect limited volatility around the earnings announcement.

Options are pricing ±1.4% while BSX has averaged ±5.3% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.4%

30d HV

59.7%

Calls (28.2M)P/C Ratio: 0.21Puts (7.0M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Boston Scientific beats expectations, history suggests the stock could rise by an average of 0.45% in the following day, confirming the company's strong momentum.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction, reflecting cautious investor sentiment.

Miss

In the event of a miss, the stock could decline significantly, as seen in past reactions where misses led to notable drops.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in their medical devices.
2Insights into market demand trends in key segments like cardiology and urology.
3Management's outlook on future revenue growth and market expansion.
4Details on cost management and operational efficiencies.
5Any commentary on competitive pressures in the healthcare equipment industry.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Feb8

HMYReported

Harmony Gold Mining Company Limited

RecapView

Feb8

CNAReported

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, crucial for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BSX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+5.92%

Avg Stock Reaction

+0.45%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

The optimistic view hinges on Boston Scientific continuing its strong performance, potentially reporting higher-than-expected EPS and revenue growth, which could drive the stock higher.

Bear Case

On the flip side, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, especially given the recent volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's history of beating EPS estimates, this number will be crucial for investor sentiment and stock performance.

How is revenue growth trending in key segments?

Understanding revenue growth in critical areas will help gauge the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Boston Scientific's ability to continue its streak of EPS beats, especially given its recent operational improvements.

Supporting Evidence

The company has consistently surprised on the upside with a 100% EPS beat rate over the last eight quarters.

The options market is pricing a lower move than historical averages, suggesting potential for greater volatility.

Recent performance trends indicate strong demand in key segments, which may not be fully reflected in current estimates.

Key Risk

If the EPS comes in below $0.75, it could challenge the current positive sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized, especially given the company's strong track record of beating EPS estimates.

Bull Confirmed If

An EPS of $0.85 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.75 would signal potential issues, confirming the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±1.36%

Historical Avg

±5.3%

Pricing cheap

The options market is pricing in a modest move of about 1.36%, suggesting that traders expect limited volatility around the earnings announcement.

Options are pricing ±1.4% while BSX has averaged ±5.3% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.4%

30d HV

59.7%

Calls (28.2M)P/C Ratio: 0.21Puts (7.0M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Boston Scientific beats expectations, history suggests the stock could rise by an average of 0.45% in the following day, confirming the company's strong momentum.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction, reflecting cautious investor sentiment.

Miss

In the event of a miss, the stock could decline significantly, as seen in past reactions where misses led to notable drops.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in their medical devices.
2Insights into market demand trends in key segments like cardiology and urology.
3Management's outlook on future revenue growth and market expansion.
4Details on cost management and operational efficiencies.
5Any commentary on competitive pressures in the healthcare equipment industry.